Examples of 'triple-negative' in a sentence
Meaning of "triple-negative"
Triple-negative (adjective): Refers to a type of breast cancer that lacks three important receptors. This term is commonly used in the medical field to describe a specific characteristic of cancer cells
How to use "triple-negative" in a sentence
Basic
Advanced
triple-negative
They are called triple-negative breast cancers.
Triple-negative breast cancer is a subtype of breast cancer.
This protein fuels triple-negative breast cancer.
Triple-negative breast cancer is aggressive and difficult to treat.
Especially in triple-negative breast cancer.
Triple-negative breast cancers comprise a very heterogeneous group of cancers.
Anyone can be diagnosed with triple-negative breast cancer.
Triple-negative breast cancer is an aggressive disease that presents an enormous clinical challenge.
Methods for predicting response of triple-negative breast cancer to therapy.
Triple-negative breast cancer is an aggressive disease that poses a significant clinical challenge.
A disproportionate numbers of cases of triple-negative breast cancer affect African-American women.
Triple-negative breast cancer is an aggressive disease, with high unmet medical need.
All five variants were also associated with triple-negative disease in a population sample.
Triple-negative breast cancer is an aggressive form of cancer that usually affects young women.
Radiation is another potential treatment for people with triple-negative breast cancer.
See also
Different subtypes of triple-negative breast cancer respond to different therapies.
Biomarker predicts poor prognosis in African-Americans with triple-negative breast cancer.
Novel technique switches triple-negative breast cancer cells to hormone-receptor positive cells.
Immunotherapy may be used to treat locally advanced or metastatic triple-negative breast cancer.
Triple-negative breast cancers can be further subdivided into different classes, one of which is immunomodulatory.
Prognostic biomarker and possible drug target uncovered in triple-negative breast cancer.
That 's a very famous triple-negative phrase that effectively says that action without evidence is justified.
Even its name is daunting to women diagnosed with it - triple-negative breast cancer.
Tissues from those with triple-negative inflammatory breast cancer received the most promising results.
There are no targeted drugs available for patients with triple-negative breast cancer.
Triple-negative breast cancer is a subtype that does not express hormone receptor or HER2.
For example, having a type of breast cancer called triple-negative seems to increase risk.
Triple-negative tumors can not be treated with endocrine therapy or therapies targeted to HER2.
The new research shows how to exploit a weakness in some triple-negative breast cancers.
Researcher finds most triple-negative breast cancers express muc-1 target.
Research team explores nanotechnology-based therapeutic strategy for triple-negative breast cancer.
Unlike the three main types, triple-negative breast cancer has no targeted therapies available, currently.
Her research goal is to better understand the therapeutic approach to triple-negative breast cancer.
Seen from the genetic perspective too, both triple-negative and basal-like breast cancers are greatly heterogeneous.
Currently, few treatments target the unique molecular features of triple-negative breast cancer.
Triple-negative breast cancer ( TNBC ) is particularly aggressive and difficult to treat.
Tumors that lack high expression of these markers and are classified as triple-negative tumors.
Researchers examined this relationship in triple-negative breast cancer cell lines and in mouse models.
We have tested these nanostructure particles in animals using a highly aggressive form of triple-negative breast cancer.
Surgery is often used to treat triple-negative and basal-like breast cancer.
Some studies suggest that certain backgrounds may make people more susceptible to triple-negative breast cancer.
A Tru-Cut biopsy led to the diagnosis of a triple-negative nuclear grade 2 invasive ductal carcinoma.
Keep in mind, not all breast cancers from BRCA mutations are triple-negative.
Immunohistochemical profile of triple-negative tumors is summarized in Table 2.
The existing drug estradiol can inhibit tumor growth in a subtype of triple-negative breast cancer.
Triple-negative cancers, or TNBC, also tend to be more aggressive than other cancer subtypes.
Activated STAT3 is part of an important oncogenic pathway in triple-negative breast cancers.
Image, Morphologic variants of triple-negative breast cancer ( TNBC ) with different genetic alterations.
The molecule the Norwegian researchers have now found controls the triple-negative breast cancer cell division.
Medical News Today, Triple-negative breast cancer, Recurrence and survival rates.
